AUGUST 22, 2016
Status as of August 10, 2016:
- The sole manufacturer of vigabatrin is currently out-of-stock
- The major Canadian distributors we have contacted have either very low levels of inventory or have no
- Some pharmacies still have vigabatrin in inventory
- Lundbeck LLC posted a drug shortage notice on drugshortages.ca on August 9. The reason given for
the shortage is “Unexpected manufacturing delays”.
- Both the tablets and the powder formulation (sachets) are listed on the drugshortages.ca reporting
o 500 mg Sabril tablets, drug identification number 02065819, estimated resupply date: Sept. 1
o 500 mg Sabril powder, drug identification number 02068036, estimated resupply date: Sept.
Update: June 23, 2016
via Canadian Epilepsy Alliance Drug Shortage Committee
Clobazam is in short supply, but this drug is still available at some pharmacies. If inventories have become low or depleted at your pharmacy, ask your pharmacist to recheck the status of both generic clobazam and Frisium (brand name) with their suppliers.
Distributors have started receiving shipments this week of generic clobazam (Apo-clobazam, Apotex Inc.). The new stock will be spread across the country. There may restrictions on the amounts available to individual pharmacies until the supply situation stabilizes. A second replenishment of generic clobazam (Apo-clobazam, Apotex Inc.) is expected to arrive at pharmacies by early July.
It is expected that there will also be periodic shipments of the brand name product (Frisium, Lundbeck LLC) over the coming weeks as
April 22, 2016
Currently, there is some availability of generic divalproex.
According to information posted by Teva Canada Limited on drugshortages.ca, shipments of Teva-Divalproex tablets were expected to be sent to wholesalers the week of April 4 (250mg) and the week of April 18 (500mg). There has been no recent resupply of the 125mg Teva-Divalproex tablets, the estimated resupply date is May 31.
Apotex provided new updates on April 21. They are beginning to resupply Apo-Divalproex, starting with the 500mg tablets. Some inventory of this strength tablet is expected to ship to wholesalers on April 22. The estimated resupply dates for Apo-Divalproex are May 9 (500mg), May 31 (250mg) and July 31 (125mg).
Epival is expected to remain in shortage for the coming months. A recent update from BGP Pharma on
Update - July 14th, 2015
Apo-clobazam shortage is resolved. The drug identification number or DIN is 02244638.
Please note that PMS-clobazam, marketed by Pharmascience Inc, has been discontinued and is no longer available in Canada. A notice of this drug discontinuation is posted on www.drugshortages.ca. The drug identification number or DIN is 02244474.
Acetazolamide tablets are available again from AA Pharma. The drug identification number or DIN is 00545015.
Please note that Acetazolam (Valeant Canada LP) is no longer available, this product has been discontinued. A notice of this drug discontinuation is posted on www.drugshortages.ca. The drug identification number or DIN is